Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Blaisdell

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Blood Cells, Molecules & Diseases|December 17, 2008
A potentially deleterious new CYP2C9 polymorphism identified in an African American patient with major hemorrhage on warfarin therapyJ A Goldstein, J A Blaisdell, N A Limdi
Journal of Biochemical and Molecular Toxicology|September 16, 1999
Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2CsT S Klose, J A Blaisdell, J A Goldstein
Archives of Biochemistry and Biophysics|August 29, 1998
Cloning and expression of murine CYP2Cs and their ability to metabolize arachidonic acidG Luo, D C Zeldin, J A Blaisdell, et al.
Biochemistry|April 2, 1991
Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamilyM Romkes, M B Faletto, J A Blaisdell, et al.
Biochemistry|February 9, 1993
Cloning and expression of complementary DNAs for multiple members of the human cytochrome PH50IIC subfamilyM Romkes, M B Faletto, J A Blaisdell, et al.
Pharmacogenetics|October 23, 2001
Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acidD Dai, D C Zeldin, J A Blaisdell, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Blood Cells, Molecules & Diseases|December 17, 2008
A potentially deleterious new CYP2C9 polymorphism identified in an African American patient with major hemorrhage on warfarin therapyJ A Goldstein, J A Blaisdell, N A Limdi
Journal of Biochemical and Molecular Toxicology|September 16, 1999
Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2CsT S Klose, J A Blaisdell, J A Goldstein
Archives of Biochemistry and Biophysics|August 29, 1998
Cloning and expression of murine CYP2Cs and their ability to metabolize arachidonic acidG Luo, D C Zeldin, J A Blaisdell, et al.
Biochemistry|April 2, 1991
Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamilyM Romkes, M B Faletto, J A Blaisdell, et al.
Biochemistry|February 9, 1993
Cloning and expression of complementary DNAs for multiple members of the human cytochrome PH50IIC subfamilyM Romkes, M B Faletto, J A Blaisdell, et al.
Pharmacogenetics|October 23, 2001
Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acidD Dai, D C Zeldin, J A Blaisdell, et al.
Pageof 1